Metadate en es it fr

Metadate Brand names, Metadate Analogs

Metadate Brand Names Mixture

  • No information avaliable

Metadate Chemical_Formula


Metadate RX_link

Metadate fda sheet

Metadate FDA

Metadate msds (material safety sheet)

Metadate MSDS

Metadate Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Metadate Molecular Weight

233.306 g/mol

Metadate Melting Point


Metadate H2O Solubility


Metadate State


Metadate LogP


Metadate Dosage Forms

Tablets; Tablets (sustained release)

Metadate Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Metadate Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Metadate Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Metadate side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Metadate Patient Information

Metadate Organisms Affected

Humans and other mammals